Crispr Therapeutics shares owned by Griffin Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Griffin Asset Management
from 13F filings
Historical chart of Griffin Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Griffin Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Griffin Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $714k | 11k | 68.16 |
| 2023-12-31 | $654k | 11k | 62.60 |
| 2023-09-30 | $459k | 10k | 45.39 |
| 2023-06-30 | $210k | 3.7k | 56.14 |
| 2021-09-30 | $345k | 3.1k | 111.94 |
| 2021-06-30 | $862k | 5.3k | 161.85 |
| 2021-03-31 | $216k | 1.8k | 121.62 |
| 2019-06-30 | $64k | 1.4k | 47.06 |
More positions owned by Griffin Asset Management
Home Depot (HD)
View all positions for Griffin Asset Management